Introduction
                Concern for the adverse health impacts of air 
                  pollution continues to be the principal (although not sole) 
                  motivation for air quality and source emissions regulations.  
                  Accordingly, the need to better serve research on air 
                  quality-health relationships is a major justification for improving 
                  the speciation of organic environmental air contaminants.  
                  
                Many air contaminants of health and regulatory 
                  concern are wholly or in part organic carbon.  
                  For example, among the six National Ambient Air Quality 
                  Standards (NAAQS) pollutants there is considerable current concern 
                  for the health impacts of ambient particulate matter (PM) (EPA, 
                  2003).  A small fraction 
                  of coarse PM mass (PM10-2.5) consists of organic 
                  material of animal or plant origin, or is contaminated by natural 
                  (e.g., bacterial endotoxin, plant pollen protein) or anthropogenic 
                  (e.g., condensed combustion products) organic carbon.  
                  However, organic carbon, largely anthropogenic, typically 
                  comprises 20-40% of fine PM (PM2.5).  
                  Within PM2.5, there is considerable interest 
                  in, but little knowledge about, the health implications of the 
                  “ultrafine” (nominally £100 
                  nm) and “nanoparticle” (nominally £ 50 nm) fractions, which although comprising a minor portion 
                  of total PM mass, dominate PM counts.  
                  These smallest fractions of ambient PM contain greater 
                  portions of organic carbon than PM2.5; indeed, many 
                  nanoparticles consist almost entirely of condensed semi-volatile 
                  organic compounds (SVOCs), or non-volatile organics.  
                  Beyond the NAAQS, EPA identified 188 Hazardous Air Pollutants 
                  (HAPs) considered to present important health hazards <http://www.epa.gov/ttn/atw/pollsour.html>, the majority 
                  of which are organic carbon compounds or classes.  Among the HAPs, EPA has identified 33 Urban 
                  Air Toxics (UATs) of greatest concern 25 <http://www.epa.gov/ttn/atw/urban/list33.html>, 
                  25 of which are organic carbon compounds or classes.   
                People always breathe complex mixtures of many 
                  air contaminants from many natural and anthropogenic sources.  There is growing recognition of the need for 
                  a better understanding of the contributions of the many different 
                  individual air contaminants, and classes of contaminants, to 
                  the health effects associated statistically with air pollution.  
                  Although some efforts have been directed toward “dissecting” 
                  the chemical species responsible for the biological effects 
                  of certain source emissions, most ambient air quality health 
                  research has focused on individual pollutants.  
                  This approach has fostered considerable improvement in 
                  air quality to date, but the relationship between air quality 
                  and health is unavoidably a multi-pollutant, multi-source issue.  
                  To better understand the relationship, we need to answer 
                  several interrelated questions.  Which air contaminants are causally related 
                  to which health effects?  Which 
                  are the most important?  To 
                  what extent can we lump pollutants and pollutant classes for 
                  regulatory purposes?  What are the contributions and relative importance 
                  of different pollution sources?  
                  Are there combinations of air contaminants for which 
                  we should be concerned (i.e., that have health impacts different 
                  from those predicted on the basis of the single components)?  
                  What plausible changes in air quality would yield the 
                  greatest, most cost-effective benefit?  
                  A fundamental question underlies these issues: what is 
                  the relationship between the composition of complex pollutant 
                  mixtures and their health hazards and risks?
                Moving beyond our present understanding of 
                  the air quality-health relationship will require a better understanding 
                  of exposure which, among other needs, will require more detailed 
                  information on the physical-chemical species of organic carbon 
                  compounds to which people are exposed.
                Findings
                Answers to the Questions
                 1)       Is 
                  there good evidence for the health importance of organic air 
                  contaminants?
                Yes! 
                The NAAQS for PM2.5, the list of 
                  HAPs, and the subgroup of UATs would not exist if there were 
                  not substantive evidence that at some level of exposure, these 
                  air contaminants are harmful to health.  There is a huge literature demonstrating that 
                  individual organic compounds and classes that are present as 
                  air contaminants are harmful to health.  
                  No attempt is made here to review that literature, but 
                  one has only to access the information sources cited in the 
                  introduction to gain an appreciation for its extent. 
                There is information from human and/or animal 
                  studies that the individual HAPs, and many organic species not 
                  included in the HAPs, can, at some dose, cause a wide spectrum 
                  of adverse health effects including irritation, inflammation, 
                  non-cancer diseases of multiple organs, cancer (or effects leading 
                  to cancer), birth defects, neurological abnormalities, and enhancement 
                  of allergic responses.  A 
                  few recent examples will illustrate the spectrum of evidence.  An epidemiology study demonstrated associations 
                  between cardiovascular emergency department visits in Atlanta, 
                  GA and PM-borne elemental carbon, organic carbon, and oxygenated 
                  hydrocarbons, among other pollutants (Metzger et al., 2004).  
                  Using filtered and unfiltered diesel emissions, it was 
                  shown that gases, vapors, and nanoparticles were more responsible 
                  than “soot” for lung inflammation in experimentally exposed 
                  humans (Rudell et al., 1999).  Personal exposure to PM2.5 and polycyclic 
                  aromatic hydrocarbons (PAHs) were found to correlate with the 
                  level of DNA adducts (abnormal attachments of organic moieties 
                  to DNA) in both a general population and coke oven workers in 
                  the Czech Republic (Lewtas, et al., 1997).  
                  The organic components of combustion PM (including SVOC 
                  species) were found to amplify human nasal allergic responses 
                  (Nel et al., 2001).  PM 
                  and vapor-phase SVOC fractions of emissions from different vehicles 
                  was found to vary considerably in toxicity in animal lungs (Seagrave 
                  et al., 2002), and statistical analysis of composition-response 
                  relationships revealed that hopanes and stearanes, markers of 
                  engine oil, co-varied most closely with toxicity (Mauderly et 
                  al., 2003).  Detailed 
                  analysis of the composition of petroleum samples allowed differences 
                  in mutagencicity in bacteria to be associated with certain chemical 
                  “fingerprints” (Eide et al., 2002).
                 2)       How 
                  is our current knowledge of the air quality-health relationship 
                  limited by the present lack of analytical data?
                You can’t study what you don’t measure!
                Most research funding is focused on single 
                  pollutants or sources involved in regulatory debates, and the 
                  majority of debate is driven by reviews of the NAAQS.  
                  Among the NAAQS, only the PM standard involves organic 
                  carbon.  Although research 
                  advisors have noted the need to better understand the contribution 
                  of organic carbon to PM effects (NRC, 2003), efforts to date 
                  have not been widespread.  A 
                  major factor is that epidemiology has largely relied on “exposure” 
                  (ambient air quality) data collected for regulatory compliance, 
                  and there is no current requirement to measure anything other 
                  than PM mass concentrations.  (HAPs are “controlled” on the basis of source emission factors, 
                  not on the basis of measured ambient concentrations.)  The complexity and cost of sampling and analysis for detailed organic 
                  speciation hinders its deployment in prospective epidemiology.  Similarly, although laboratory health studies 
                  are prospective in nature, conducted in a single research environment, 
                  and could take advantage of contemporary organic speciation 
                  methods, few studies have done so.  
                  A limited number of studies have incorporated analyses 
                  of exposures to organic carbon at various levels of detail, 
                  but overall, the lack of exposure data has severely limited 
                  research on the health impacts of organic carbon.  
                Health research is also limited by the sparse 
                  characterization of ambient airborne organic matter aside from 
                  “health” studies.  For 
                  example, a better understanding of the spatial homogeneity of 
                  classes of organic matter would allow epidemiologists to more 
                  efficiently incorporate organic analyses into prospective studies.  
                  It is presently difficult to judge the number and location 
                  of samplers necessary to address exposure-effect hypotheses.  
                  Similarly a better understanding of the co-variance of 
                  concentrations of different classes of organic compounds among 
                  locations would facilitate study design.  Many classes of organic and inorganic pollutants 
                  co-vary because they are derived from the same sources and/or 
                  are affected similarly by meteorology.  
                  Knowledge of locations where, and the extent to which, 
                  different classes of organics might be “unlinked” would greatly 
                  facilitate the targeting of environmental studies to resolve 
                  exposure-effect relationships.
                Although even the current state-of-the-science 
                  limits the extent to which complex organic composition can be 
                  resolved, the principal problem of past research has not been 
                  an inability to conduct analyses (i.e., analytical capability).  
                  The principal problem has been a failure to incorporate 
                  analyses into research programs and individual experimental 
                  designs (i.e., analytical availability).   
                 3)       How 
                  could health researchers utilize improved information?
                In many ways!  The problem is not 
                  a lack of plausible research strategies, it’s primarily a lack 
                  of incorporation of organic speciation measurements into health 
                  research protocols.
                The full range of demonstrated and potential experimental designs will 
                  not be discussed in detail here, but the following examples 
                  illustrate a spectrum of research strategies in which health 
                  researchers could make use of improved organic speciation.  
                  Improvements are needed in both the amount of data that 
                  are generated, and the detail with which organic composition 
                  is resolved. 
                One general strategy is to test statistical associations 
                  between exposures of humans to organic species and adverse health 
                  outcomes.  Epidemiological 
                  studies test statistical relationships between exposures and 
                  health outcomes among either small, select populations (“panel 
                  studies”) or larger area populations (“ecological studies”).  
                  The degree to which such studies can detect effects of 
                  organic compounds depends on the accuracy with which the exposures 
                  are actually known.  Samplers attached to the individual or in the individuals’ specific 
                  locations can provide specific exposure information in panel 
                  studies.  Larger area 
                  samples are typically used in ecological studies.  
                  An example is the recent finding of an association between 
                  cardiovascular emergency department visits and concentrations 
                  of organic components of PM in the Atlanta, GA area (Metzger 
                  et al., 2004).  The Aerosol Research and Inhalation Epidemiology 
                  Study (ARIES) is among the few attempting to include classes 
                  of organic carbon in city-scale epidemiology (Van Loy et al., 
                  2000).  In some cases, biological markers of exposure 
                  to organic species can be used to better test links between 
                  exposures and health outcomes (Talaska et al., 1996).  
                  For example, Lewtas et al. (1996) linked increased concentrations 
                  of DNA adducts in blood cells of general and worker populations 
                  to levels of exposure to PAHs.  
                  The use of chemical analysis for source apportionment 
                  can also contribute to the interpretation of population studies 
                  (e.g., Maykut et al., 2003).  
                A second general strategy is to intentionally expose 
                  biological systems (e.g., humans, animals, or cultured bacteria 
                  or mammalian cells) to specific organic compounds and examine 
                  specific biological responses.  
                  This strategy can involve administration of either selected 
                  compounds or complex mixtures.  Nels et al. (2001) for example, used complex 
                  organic extracts to determine that the organic fraction of diesel 
                  soot plays a role in amplifying human nasal immune and inflammatory 
                  responses to allergens, and then used a single compound to determine 
                  that pyrene, a “model” PM-associated PAH, can also cause the 
                  effect.  This general 
                  approach is the one most widely used to test the toxicology 
                  of compounds in animals, and has provided much of the data supporting 
                  selection of the HAPs.  
                A third general strategy uses “chemical dissection” 
                  to determine the compounds or classes primarily within complex 
                  mixtures that drive a health response.  
                  The best-known example is the “biodirected fractionation” 
                  of solvent extracts of combustion PM, in which progressive fractionation 
                  and testing of organic matter proved that nitroaromatic compounds 
                  are largely responsible for mutagenic activity in bacteria (Scheutzle 
                  and Lewtas, 1986).  Testing 
                  the roles of organic extracts vs. black carbon in the nasal 
                  immune response to diesel soot (Nels et. al, 2001), and testing 
                  the effects of filtered and unfiltered engine emissions on lung 
                  inflammation (Rudel et al., 1999), are variants of this approach.  
                  Current analytical technology is usually adequate for 
                  studies of single known compounds.  
                  One example of a potential inadequacy is the lack of 
                  information on the health importance of the “unresolved complex 
                  mixture” that is not currently collected or speciated in analyzing 
                  complex organic mixtures.  It 
                  would be useful to isolate quantities of unresolved material 
                  sufficient for toxicity screening in simple biological systems.  If the material is shown to have biological activity, resolving 
                  its composition and sources would be important. 
                A fourth general strategy involves the use of “statistical 
                  dissection” to determine the components of complex mixtures 
                  causing health responses.   
                  If composition and responses are measured identically 
                  for all multiple complex exposures having different but overlapping 
                  compositions, the results can be combined into a composition-response 
                  data matrix and analyzed statistically to determine the physical-chemical 
                  species that co-vary most closely with differences in response.  
                  An example of this approach is the use of Principal Component 
                  Analysis and Partial Least Squares Regression (PCA/PLS) to determine 
                  the compounds in petroleum samples contributing most strongly 
                  to mutagenicity in bacteria (Eide et al., 2002).  
                  Another recent example is the use of PCA/PLS to determine 
                  that engine oil components contributed most strongly to differences 
                  in lung toxicity among a set of engine emission samples (Mauderly 
                  et. al., 2003).  
                Overall, there is ample opportunity for a greater incorporation 
                  of organic analyses into health research.  In some cases, adequate analytical technology 
                  exists, and the issue is directing greater attention to health 
                  research on organic components of air pollution.  In some cases, analytical instrumentation exist as research tools, 
                  but are not evolved into packages sufficiently standardized, 
                  simple, and inexpensive for widespread deployment.  
                  In a few cases, current analytical capabilities may not 
                  be sufficient even as research tools.
                 4)       How 
                  can interactions between the analytical and health research 
                  communities be improved?
                We need improvements in both communication and technology!
                There needs to be more dialogue between health 
                  researchers and the analytical community.  
                  A substantial portion of the health research community 
                  are insufficiently knowledgeable about the actual composition 
                  of air pollution (especially the organic components), how pollution 
                  “works” (source emissions, transport, and atmospheric chemistry), 
                  and analytical possibilities (what can be measured and how) 
                  to conceive innovative experimental designs.  Many among the analytical community may not be sufficiently knowledgeable 
                  about the fundamentals (not the details) of the nature and range 
                  of health effects, the physical-chemical interface between airborne 
                  organic species and biological fluids and tissues, likely cellular-molecular 
                  biological mechanisms of effects, and plausible biological experimental 
                  approaches (and their inherent limitations) to perceive the 
                  range of application of their technology to health research.  
                  Not only do we need more tutorial and “brainstorming” 
                  dialogue, there also needs to be a larger number of “bridging” 
                  scientists who consider themselves part of both research 
                  communities.   
                We need to take better advantage of several 
                  pathways for cross-fertilization between analysts and biologists.  The publication by each community of its papers in its own journals 
                  is necessary and valuable, but is not an effective pathway for 
                  cross-disciplinary communication.  
                  There needs to be more development and dissemination 
                  of summary, tutorial, publications.  
                  The EPA Criteria Documents (e.g., EPA, 2003) contain 
                  the needed information for NAAQS pollutants, but few researchers 
                  read sections pertaining to other disciplines.  
                  The recent publication by NARSTO, “Particulate Matter 
                  Science for Policy Makers” (2003) is an excellent example of 
                  a tutorial synopsis that would be useful to biologists, although 
                  the title may not suggest its value to the health research community.  Developing appropriate materials is only the 
                  first step; without distribution across disciplines, communication 
                  does not occur.  Presenting 
                  both air quality and health sessions at scientific meetings 
                  in another pathway; however, the common practice of doing so 
                  in parallel sessions often hinders real cross-education.  
                  The conduct of cross-disciplinary tutorial sessions at 
                  scientific meetings (unopposed, when possible) is an excellent 
                  strategy, but not frequently implemented.  “Center” programs containing both analytical 
                  and biological components (e.g., NIEHS Environmental Centers 
                  and EPA PM Centers) can be very productive, but typically struggle 
                  to truly integrate the disciplines into unified research strategies.  
                  
                There needs to be more emphasis on training 
                  researchers that span scientific disciplines, in order to expand 
                  the number and types of scientists conceiving and conducting 
                  truly integrative research.  The NIEHS Mentored Quantitative Research Career 
                  Development program is an example of such an effort (http://grants1.nih.gov/grants/guide/pa-files/PA-99-087.html).  Federal agencies, states, and professional 
                  organizations could sponsor more training grants aimed specifically 
                  at cross-disciplinary training.
                Finally, there needs to be greater attention 
                  among funding organizations to incorporating organic analytical 
                  capabilities into health research.  
                  Simply getting the two communities to communicate is 
                  worthwhile, but does not necessarily result in joint research 
                  efforts.  Scientists 
                  are most strongly motivated to action by the structure of funding 
                  opportunities.  If research 
                  solicitations are framed to merge the two communities into joint 
                  research strategies, the scientists will conceive creative ways 
                  of doing so.  Conversely, if research solicitations do not 
                  place a premium on such interactions, they are much less likely 
                  to occur.  
                Although not the key topic of this workshop, 
                  it should be noted that a need for better cross-fertilization 
                  pertains to links within the health and analytical communities, 
                  as well as between those communities.  
                  It is clear that more strategic interactions and coordination 
                  is needed among different health disciplines and among researchers 
                  focused on different health outcomes.  It is likely that the same might be true within 
                  the analytical community.
                We also need technological advances that: 1) 
                  make a greater level of characterization of exposures to organic 
                  species practical for more widespread deployment in field and 
                  laboratory studies; and 2) provide a more thorough speciation 
                  of complex organic mixtures.  At present, the former is more critical than the latter.  We know enough to be confident that applying 
                  the current level of speciation capability more widely in health 
                  research could result in tremendous advances in our understanding 
                  of the health importance of airborne organic carbon (in all 
                  physical phases) – even though we don’t know what the answer 
                  might be.  We need to 
                  make analytical techniques and equipment more practical for 
                  wide deployment, including use by non-specialists (simpler, 
                  faster, cheaper; that’s right – all three!).  
                  It is also possible to apply advanced analytical technologies 
                  at the prototype or “research” stage in limited health studies.  
                  For example, it would be useful to know whether or not 
                  the major fraction of complex organic matter that cannot now 
                  be readily resolved might have health importance (or conversely, 
                  whether we can relax and ignore it).  Exploratory work using prototype technologies can be done with small 
                  samples and simple biological systems (e.g., cultured cells) 
                  or limited complex biological systems (i.e., instilled into 
                  lungs of small numbers of animals).  
                  
                Conclusions and Recommendations
                There is a serious need for research providing 
                  a better understanding of the health impacts of the many different 
                  air contaminants that comprise exposures to air pollution, and 
                  many of those contaminants are organic carbon compounds.  
                  That research will require various levels of speciation 
                  in order to test associations between health effects and different 
                  classes and compounds.  Both improved dialogue between the health and analytical research 
                  communities and advances in analytical technology are needed.  The key communications challenges presented 
                  to the analytical community by health research needs are to 
                  take an active role in 1) educating the health research community 
                  about exposures to organic compounds; and 2) facilitating incorporation 
                  of organic analyses into health research.  
                  The key technological challenges are to: 1) expand the 
                  range of analytical instrumentation that is sufficiently transportable 
                  and inexpensive to deploy widely in health research; and 2) 
                  to develop methods to resolve organic carbon composition more 
                  completely.
                References
                Eide, I., Neverdal, G., Thorvaldsen, B., Grung, 
                  B., Kvalheim, O. Toxicological evaluation of complex mixtures 
                  by pattern recognition: correlating chemical fingerprints to 
                  mutagenicity.  Environ. Health Perspect. 110 (Suppl 6): 985-988, 
                  2002.
                EPA, Environmental Protection Agency. Air 
                  Quality Criteria for Particulate Matter. Fourth External Review 
                  Draft, EPA/600/P-99/002, aD, bD, http://cfpub1.epa.gov/ncea/cfm/partmatt.cfm?ActType=default, June 2003.
                Lewtas, J., Walsh, D., Williams, r. Dobias, 
                  L. Air pollution exposure-DNA adduct dosimetry in humans and 
                  rodents: evidence for non-linearity at high doses. Mutat. 
                  Res. 378(1-2): 51-63, 1997.
                Maykut, N.N., Lewtas, J., Kim, E., Larson, 
                  T.V. Source apportionment of PM2.5 at an urban IMPROVE site 
                  in Seattle, Washington. Environ. Sci. Technol. 37(22): 5135-42, 2003.
                Mauderly, J.L., 
                  Seagrave, JC. McDonald, J.D., Eide, E., Zielinska, B., Lawson, 
                  D.   Relationship between composition and toxicity 
                  of engine emission samples. DEER 2003, Diesel Engine Emissions 
                  Reduction Workshop, FreedomCar and Vehicle Technologies 
                  Program, U.S. Department of Energy, Newport, RI, August 27, 
                  2003 (view presentation at www.orau.gov/DEER/DEER2003/presentations/.htm#Session%209, 
                  full paper [McDonald, et al.] submitted to Environ. Health 
                  Perspect.).
                Metzger, K.B., Tolbert, 
                  P.E., Klein, M., Peel, J.L., Flanders, W.D., Todd, K., Mulholland, 
                  J.A., Ryan, P.B., Frumkin, H. Ambient air pollution and cardiovascular 
                  emergency department visits. Epidemiology 15: 46-56, 
                  2004.
                NARSTO, North American 
                  Research Strategy for Tropospheric Ozone. Particulate Matter 
                  Science for Policy Makers: A NARSTO Assessment.  EPRI 1007735, February, 2003. Access at http://www.cgenv.com/narsto/ 
                  and click on PM Science and Assessment. Summary available in 
                  English, French, and Spanish.
                Nel, A.E., Diaz-Sanchez, 
                  D., Li, N.  The role 
                  of particulate pollutants in pulmonary inflammation and asthma: 
                  evidence for the involvement of organic chemicals and oxidative 
                  stress.  Curr. Opin. Pulm. Med. 7(1: 20-26, 2001.
                NRC, National Research 
                  Council Committee on Research Priorities for Airborne Particulate 
                  Matter. Research Priorities for Airborne Particulate Matter 
                  III, Early Research Progress, National Academy Press, Washington, 
                  DC, 2001.
                Rudell B., 
                  Blomberg A., Helleday R., Ledin M.C., Lundbäck B., Stjernberg 
                  N., Hörstedt P., Sandström T. Bronchoalveolar inflammation after 
                  exposure to diesel exhaust: comparison between unfiltered and 
                  particle trap filtered exhaust. Occup. Environ. Med. 
                  56: 527-534, 1999.
                Schuetzle D., and Lewtas J. Bioassay-directed chemical 
                  analysis in environmental research. Analyt. Chem. 58: 
                  1060A-1075A, 1986.
                Seagrave JC., 
                  McDonald J.D., Gigliotti A.P., Nikula K.J., Seilkop S.K., Gurevich 
                  M., and Mauderly J.L. Mutagenicity and in vivo toxicity of combined 
                  particulate and semivolatile organic fractions of gasoline and 
                  diesel engine emissions. Toxicol. Sci. 70: 212-226, 2002.
                Talaska, G., Underwood, P., Maier, A., Lewtas, J., Rothman, 
                  N., Jaeger, M. Polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs 
                  and related environmental compounds: biological markers of exposure 
                  and effects. Environ. Health Perspect. 104 (Suppl 5): 901-6, 1996.
                Van Loy, M., Bahadori, T., Wyzga, R., Hartsell, B., 
                  Edgerton, E. The Aerosol Research and Inhalation Epidemiology 
                  Study (ARIES): PM2.5 mass and aerosol component concentrations 
                  and sampler intercomparisons. J. Air Waste Manag. Assoc. 50(8):1446-58, 2000.
                Watts, R.R., Wallingford, K.M., Williams, R.W., House, 
                  D.E., Lewtas, J. Airborne exposures to PAH and PM2.5 
                  particles for road paving workers applying conventional asphalt 
                  and crumb rubber modified asphalt. J. 
                  Expo. Anal. Environ. Epidemiol. 
                  8(2): 213-29, 1998.